| Long-term use of proton-pump inhibitors: whole-of-population patterns in Australia 2013–2016 B Daniels, SA Pearson, NA Buckley, C Bruno, H Zoega Therapeutic advances in gastroenterology 13, 1756284820913743, 2020 | 49 | 2020 |
| Generating real-world evidence on the quality use, Benefits and safety of medicines in Australia: History, challenges and a roadmap for the future SA Pearson, N Pratt, J de Oliveira Costa, H Zoega, TL Laba, ... International journal of environmental research and public health 18 (24), 13345, 2021 | 18 | 2021 |
| Passing the acid test? Evaluating the impact of national education initiatives to reduce proton pump inhibitor use in Australia C Bruno, SA Pearson, B Daniels, NA Buckley, A Schaffer, H Zoega BMJ Quality & Safety 29 (5), 365-373, 2020 | 16 | 2020 |
| Patterns of attention deficit hyperactivity disorder medicine use in the era of new non-stimulant medicines: A population-based study among Australian children and adults (2013 … C Bruno, A Havard, MB Gillies, D Coghill, J Brett, AJ Guastella, ... Australian & New Zealand Journal of Psychiatry 57 (5), 675-685, 2023 | 14 | 2023 |
| The changing face of Australian data reforms: Impact on pharmacoepidemiology research J de Oliveira Costa, C Bruno, AL Schaffer, S Raichand, EA Karanges, ... International journal of population data science 6 (1), 2021 | 14 | 2021 |
| Variations in Long‐term Opioid Therapy Definitions: A Systematic Review of Observational Studies Using Routinely Collected Data (2000‐2019) J de Oliveira Costa, C Bruno, N Baranwal, N Gisev, TA Dobbins, ... British Journal of Clinical Pharmacology 87 (10), 3706-3720, 2021 | 11 | 2021 |
| Prescribed medicine use and extent of off‐label use according to age in a nationwide sample of Australian children AL Schaffer, C Bruno, NA Buckley, R Cairns, M Litchfield, S Paget, ... Paediatric and Perinatal Epidemiology 36 (5), 726-737, 2022 | 10 | 2022 |
| Antipsychotic Use During Pregnancy and Risk of Specific Neurodevelopmental Disorders and Learning Difficulties in Children: A Multinational Cohort Study C Bruno, CE Cesta, V Hjellvik, SP Ulrichsen, MH Bjørk, BÖ Esen, ... eClinicalMedicine, 2024 | 3 | 2024 |
| The impact of tightened prescribing restrictions on proton pump inhibitor use in Australia: An evaluation using interrupted time series analysis B Daniels, A Schaffer, NA Buckley, C Bruno, M Jun, SA Pearson, H Zoega Pharmacoepidemiology and Drug Safety 31 (3), 370-378, 2022 | 3 | 2022 |
| Children's Relative Age and Medicine Treatment for Attention-Deficit/Hyperactivity Disorder Across Australian Jurisdictions with Different School Enrolment Policies C Bruno, A Havard, M Hanly, K Falster, N Nassar, B Edwards, ... Journal of Child and Adolescent Psychopharmacology 32 (6), 349-357, 2022 | 2 | 2022 |
| Medicine treatment of glaucoma in Australia 2012–2019: prevalence, incidence and persistence B Daniels, P Healey, C Bruno, I Kaan, H Zoega BMJ Open Ophthalmology 6 (1), e000921, 2021 | 2 | 2021 |
| Coming to grips with seemingly conflicting results in programme evaluation: the devil’s in the detail B Daniels, SA Pearson, NA Buckley, C Bruno, A Schaffer, H Zoega BMJ Quality & Safety 30 (1), 70-71, 2021 | 1 | 2021 |
| Expanded access to publicly subsidised lisdexamfetamine treatment for adults with attention-deficit/hyperactivity disorder: An interrupted time-series analysis C Bruno, H Zoega, MB Gillies, A Havard, D Coghill, SA Pearson, J Brett Australian & New Zealand Journal of Psychiatry, 00048674231170556, 2023 | | 2023 |
| Patterns of ADHD medicine use: A population-based study among Australian children and adults (2013-2020) C Bruno, A Havard, M Gillies, D Coghill, J Brett, A Guastella, SA Pearson, ... PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 31, 71-71, 2022 | | 2022 |
| Prescribed medicine use in a nationwide sample of Australian children: Extent of off-label use A Schaffer, N Nassar, C Bruno, N Buckley, R Cairns, M Litchfield, S Paget, ... PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 30, 96-96, 2021 | | 2021 |
| Evaluating the impact of new prescribing restrictions for publicy-subsidised proton pump inhibitors in Australia: An interrupted time series analysis B Daniels, SA Pearson, C Bruno, N Buckley, A Schaffer, M Jun, H Zoega PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 30, 219-220, 2021 | | 2021 |
| Children's relative age and medicine treatment for attention-deficit/hyperactivity disorder (ADHD) across Australian jurisdictions with different school enrolment policies C Bruno, A Havard, M Hanly, K Falster, N Nassar, B Edwards, A Guastella, ... PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 30, 166-167, 2021 | | 2021 |
| Variations in long-term opioid use definitions in observational research: A systematic review of studies using routinely collected data JO Costa, C Bruno, N Baranwal, SA Pearson PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 29, 174-174, 2020 | | 2020 |
| The Australian pharmacoepidemiology research landscape: The more things change the more they stay the same C Bruno, JO Costa, S Raichand, SA Pearson PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 29, 494-495, 2020 | | 2020 |
| Proton pump inhibitor (PPI) use in Australia: Evaluating national quality use of medicines initiatives C Bruno, SA Pearson, B Daniels, N Buckley, H Zoega PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 28, 519-519, 2019 | | 2019 |
